Important Update on FDA Changes Concerning Peptides The US Food and Drug Administration issued national priority vouchers to companies studying psilocybin and methylone for the treatment of some mental health disorders. The vouchers were granted under The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Sermorelin vs Ipamorelin: Which peptide is right for you? NiceRx October 29, 2024 Meeting of the Pharmacy Compounding Advisory Committee